Drug Database
Back to search

Japan· JP-3954400D4080

ウロキナーゼ

A urokinase product containing ウロキナーゼ, registered in Japan by 持田製薬, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.

On Japan’s NHI price listATC B01AD04

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedウロキナーゼATCB01AD04REGISTER NO.JP-3954400D4080PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ウロキナーゼAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Urokinase is registered in 6 of 19 countries.

Countries holding a registration under ATC B01AD04 (urokinase), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 4 of them publish a price we can compare per daily dose
Search urokinase products by name

Urokinase · ATC B01AD04

6 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ウロキナーゼ
Manufacturer
持田製薬
Country
Japan (JP)
ATC code
B01AD04
ATC class
Urokinase
Defined daily dose
3 MIO, E
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

130 interactions on record for urokinase.

Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check urokinase against other medicinesHow interaction checks work

Urokinase · interactions on record

130 records

  • 46 severe
  • 84 moderate

Most severe, free to view

  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Urokinase in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All urokinase products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Urokinase Medac
  • Belgium · Actosolv, Urokinase Syner-Medica
  • Germany · Rheotromb, Syner-Kinase
  • Spain · Urokinase Teofarma, Uroquinasa Syner Medica
  • France · Actosolv, Therasolv
  • United Kingdom (Northern Ireland) · Syner-Kinase
  • Italy · Urochinasi Eg, Urokinasi Pfizer
  • Luxembourg · Actosolv
  • Netherlands · Urokinase Devrimed, Urokinase Pharma-Zentrale
  • Poland · Urokinase Medac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a6d86dbf-1c55-462d-87c9-7e8063a871e3
GET /v1/drugs/a6d86dbf-1c55-462d-87c9-7e8063a871e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "６０，０００単位１瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3954400D4080",
  "category": "注射薬",
  "price_yen": 9400,
  "generic_name": "ウロキナーゼ",
  "product_name_jp": null,
  "therapeutic_class": "3954",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about urokinase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console